Financial News
Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference
By:
Vor Biopharma via
GlobeNewswire
August 01, 2023 at 08:00 AM EDT
CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.
Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com

More News
View More
The Meteoric Rise of Rocket Lab: A Space Stock to Watch
July 11, 2025
Via MarketBeat
Tickers
RKLB
3 Hot Tech Stocks Showing Bullish Price Action Right Now
July 11, 2025
3 Stocks to Buy Ahead of the Upcoming Earnings Season
July 11, 2025
Via MarketBeat
Via MarketBeat
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.